These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17471621)

  • 1. Managing ethical performance in organizations: insights from the corporate world.
    Soule E
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S73-6; discussion S77-80. PubMed ID: 17471621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conflict-of-interest management: efforts and insights from the Association of American Medical Colleges.
    Kirch DG
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S23-5; discussion S32-7. PubMed ID: 17471619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overregulation of conflicts hinders medical progress.
    Stossel TP
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S14-5; discussion S16-22. PubMed ID: 17469469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creating an institutional conflict-of-interest policy at Johns Hopkins: progress and lessons learned.
    Miller ED
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S70-2; discussion S77-80. PubMed ID: 17469476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fostering innovation without compromising integrity.
    Pizzo PA
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S10-1; discussion 16-22. PubMed ID: 17469467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building and retaining trust in the biomedical community.
    Thornburgh D
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S38-44; discussion S51-9. PubMed ID: 17469472
    [No Abstract]   [Full Text] [Related]  

  • 7. Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants.
    Weinfurt KP; Dinan MA; Allsbrook JS; Friedman JY; Hall MA; Schulman KA; Sugarman J
    Acad Med; 2006 Feb; 81(2):113-8. PubMed ID: 16436571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings of a national dialogue on biomedical conflicts of interest and innovation management. September 20, 2006. Cleveland, Ohio, USA.
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S3-80. PubMed ID: 17566157
    [No Abstract]   [Full Text] [Related]  

  • 9. The rapidly changing landscape of biomedical conflicts of interest.
    Chisolm GM
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S3-5. PubMed ID: 17552087
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical devices and conflict of interest: unique issues and an industry code to address them.
    LaViolette PA
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S26-8; discussion S32-7. PubMed ID: 17469470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prologue: a case study in biomedical conflicts.
    Totenberg N
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S8-9; discussion 16-22. PubMed ID: 17471618
    [No Abstract]   [Full Text] [Related]  

  • 12. The mandate of innovation management.
    Cosgrove DM
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S6-7. PubMed ID: 17554813
    [No Abstract]   [Full Text] [Related]  

  • 13. Innovation and industry-academia interactions: where conflicts arise and measures to avoid them.
    Vagelos PR
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S12-3; discussion 16-22. PubMed ID: 17469468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond disclosure: the necessity of trust in biomedical research.
    Kahn JP
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S49-50; discussion S51-9. PubMed ID: 17469474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conflicts of interest at the NIH--resolving the problem.
    Steinbrook R
    N Engl J Med; 2004 Sep; 351(10):955-7. PubMed ID: 15342801
    [No Abstract]   [Full Text] [Related]  

  • 16. Public health, academic medicine, and the alcohol industry's corporate social responsibility activities.
    Babor TF; Robaina K
    Am J Public Health; 2013 Feb; 103(2):206-14. PubMed ID: 23237151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Academic medical centers and conflicts of interest.
    Poses RM; Silverstein S; Smith WR
    JAMA; 2006 Jun; 295(24):2846-7; author reply 2848-9. PubMed ID: 16804145
    [No Abstract]   [Full Text] [Related]  

  • 18. A Content Analysis of Patient Advocacy Organization Policies Addressing Institutional Conflicts of Interest.
    Brems JH; McCoy MS
    AJOB Empir Bioeth; 2019; 10(4):215-221. PubMed ID: 31593523
    [No Abstract]   [Full Text] [Related]  

  • 19. The troublesome semantics of conflict of interest.
    Friedman PJ
    Ethics Behav; 1992; 2(4):245-51. PubMed ID: 11651613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fraud, conflict of interest, and other enforcement issues in clinical research.
    Sheehan JG
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S63-7; discussion S68-9. PubMed ID: 17471620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.